translate English to French: The guidelines provided here are based on earlier guidelines developed by the consultant members of the Breast Tumor Panel of the Canadian Reference Centre for Cancer Pathology (March 1995)3, the National Coordinating Group for Breast Screening Pathology (1995)4, the European Guidelines for Quality Assurance in Mammography Screening (2001)5, the Association of Directors of Anatomic and Surgical Pathology (1996)6, the National Cancer Institute of Canada Consensus Conference on Synoptic Reporting (1998), and existing checklists from the British Columbia Cancer Agency and various laboratories across Canada.
Le présent document est fondé sur des lignes directrices élaborées par les conseillers du groupe d'experts sur les tumeurs du sein du Centre canadien de consultation en pathologie oncologique (mars 1995)3, le National Coordinating Group for Breast Screening Pathology (1995)4, ainsi que sur les European Guidelines for Quality Assurance in Mammography Screening (1996)5, les lignes directrices de la Association of Directors of Anatomic and Surgical Pathology (1996)6, la Consensus Conference on Synoptic Reporting de l'Institut national du cancer du Canada (1998), et les listes de contrôle existantes de la British Columbia Cancer Agency et de plusieurs laboratoires canadiens.